Thedrez P, Blottiere H, Chatal J F, Grzyb J, Douillard J Y
Tumour Biol. 1986;7(2-3):137-45.
F(ab')2 fragments of monoclonal antibody (MoAb) 19-9 with specificity for human colorectal adenocarcinomas were labeled with 111In or 131I and infused into nude mice bearing the human adenocarcinoma HT 29 in order to compare their preferential biodistribution according to the radiolabel used. Animal tissue distribution measured one day and five days after infusion showed that tumor accumulation was greater for 111In than for 131I. However, non specific binding of 111In labeled MoAb 19-9 was also greater in normal tissue than 131I labeled antibody, except in blood. Therefore, the tumor/normal tissue ratios were to the advantage of 131I MoAb 19-9 and a better contrast was obtained on imaging with 131I as compared to 111In labeled MoAb 19-9. Based on this experimental model 111In does not seem to be the optimal candidate for tumor imaging using radiolabeled MoAb.
对人结肠腺癌具有特异性的单克隆抗体(MoAb)19-9的F(ab')2片段用111铟或131碘进行标记,然后注入携带人腺癌HT 29的裸鼠体内,以比较根据所用放射性标记物其优先生物分布情况。注入后一天和五天测量的动物组织分布显示,111铟标记的肿瘤蓄积比131碘标记的更大。然而,111铟标记的MoAb 19-9在正常组织中的非特异性结合也比131碘标记的抗体更大,但血液中除外。因此,肿瘤/正常组织比值有利于131碘标记的MoAb 19-9,与111铟标记的MoAb 19-9相比,用131碘成像时获得了更好的对比度。基于该实验模型,111铟似乎不是使用放射性标记MoAb进行肿瘤成像的最佳候选物。